Age (mean ± SD), years | 69.90 ± 17.83 |
Male gender [n (%)] | 81 (55.9) |
Presence of comorbidities* [n (%)] | 127 (87.6) |
Exposure to a positive SARS-CoV-2 patient [n (%)] | 9 (6.2) |
Fever and dry cough at presentation [n (%)] | 30 (20.7) |
Lymphocytes [median; (IQR)] | 1100 (800.0) |
C-reactive protein [median; (IQR)], mg/dL | 8.99 (15.4) |
Procalcitonin [median; (IQR)], ng/mL | 0.2 (1.0) |
LDH [median; (IQR)], U/L | 250 (128.0) |
Positive respiratory viruses test (other than SARS-CoV-2) [n (%)] | 7 (4.8) |
Positive Legionella pneumophila or Streptococcus pneumoniae urinary antigen tests [n (%)] | 3 (2.1) |
Presence of chest CT typical features [n (%)] | 57 (39.3) |
Positive SARS-CoV-2 RT-PCR [n (%)] | 23 (15.9%) |